• Find an Expert
  • Contact
  • SearchSearch icon
  • Menu
  • Help
  • Report an issue

Contact


Email

alexander.thompson1@unimelb.edu.au

Credentials


Position
Honorary (Fellow)
Medical Bionics Department
ORCID

0000-0002-8012-872X

Dr Alexander Thompson

Honorary (Fellow)
Medical Bionics Department

515 Scholarly works
1 Projects

HIGHLIGHTS

  • 2025

    Conference Proceedings

    Long-term outcomes after endoscopic eradication therapy for dysplastic and T1a adenocarcinoma–related Barrett's esophagus: higher rate of late dysplastic recurrence with radiofrequency ablation monotherapy
    DOI: 10.1016/j.gie.2025.01.026
  • 2025

    Journal article

    Selective Optogenetic Inhibition of Slow Conducting Fibers at the Level of the Sciatic Nerve Trunk in the Mouse
    DOI: 10.1016/j.neurom.2025.09.304
  • 2025

    Journal article

    Spatially precise activation of the mouse cochlea with a multi-channel hybrid cochlear implant
    DOI: 10.1088/1741-2552/add091
  • 2024

    Journal article

    Combined-electrical optogenetic stimulation but not channelrhodopsin kinetics improves the fidelity of high rate stimulation in the auditory pathway in mice
    DOI: 10.1038/s41598-024-71712-9
  • 2024

    Conference Proceedings

    ANTI- HBS IMMUNE COMPLEX LEVELS: A NOVEL BIOMARKER OF HEPATITIS FLARE IN PATIENTS WITH HBEAG-NEGATIVE CHRONIC HEPATITIS B WHO STOP NUCLEOS( T) IDE ANALOGUE THERAPY
  • 2024

    Conference Proceedings

    The accelerated impact of alcohol-associated hepatitis on healthcare utilisation during the COVID-19 pandemic: An Australian multicentre analysis.
  • 2023

    Research grants (ARC, NHMRC, MRFF)

    Identifying Advanced Liver Fibrosis in Primary Care
Alexander Thompson

RECENT SCHOLARLY WORKS

  • 2024

    Journal article

    Improving Hepatocellular Carcinoma Surveillance Outcomes in Patients with Cirrhosis after Hepatitis C Cure: A Modelling Study
    DOI: 10.3390/cancers16152745
  • 2024

    Journal article

    Individualizing the Approach to Stopping Nucleos(t)ide Analogs: Can We Use a Low HBsAg Threshold to Predict a High Chance of Functional Cure and Minimal Risk of Hepatic Decompensation?
    DOI: 10.14309/ajg.0000000000002766
  • 2024

    Journal article

    Different Patterns of Care and Survival Outcomes in Transplant-Centre Managed Patients with Early-Stage HCC: Real-World Data from an Australian Multi-Centre Cohort Study
    DOI: 10.3390/cancers16111966
  • 2024

    Journal article

    Surveillance MRI is associated with improved survival in patients with primary sclerosing cholangitis
    DOI: 10.1097/HC9.0000000000000442

We acknowledge and pay respect to the Traditional Owners of the lands upon which our campuses are situated

Read about our commitment to reconciliation  

About us  

Careers at Melbourne  

Safety and respect  

Newsroom  

Contact  

Phone: 13 MELB ( 13 6352)

International: +61 3 9035 5511


Address:
The University of Melbourne
Grattan Street, Parkville,
Victoria, 3010, Australia


View all Campus locations  
facebookIconlinkedinIconinstagramIcontwitterIcon

Emergency information  |  Disclaimer and copyright  |  Accessibility  |  Privacy  |  VaxFACTS

CRICOS number: 00116K     ABN: 84 002 705 224